Marvel Studios president Kevin Feige may have recently revealed that there were days on Avengers: Doomsday where 30 to 35 ...

Every week is fashion week for Doechii and Lady Gaga. The artists have teamed up for “Runway,” a new collaboration that appears in the final trailer for The Devil Wears Prada 2. “Serve a little sass, ...

- Poster on previously shared positive results from DELIVER clinical trial in Duchenne muscular dystrophy (DMD) contextualizes observed clinical measures of functional improvement for managed care ...

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 11 Best Day Trading Stocks to Buy Now. Earlier this month, Dyne Therapeutics Inc. (NASDAQ:DYN) announced important updates for its DMD and DM1 ...

Olive Nwosu's first feature centers around a Lagos cab driver who accepts a gig shuttling her childhood friend and other sex workers around the city. By Jourdain Searles While a fuel crisis plagues ...

Note: This story contains spoilers from “Bridgerton” Season 4, Part 2. While the “Bridgerton” Season 4 finale saw Lady Danbury (Adjoa Andoh) and Queen Charlotte (Golda Rosheuvel) share a tender ...

Penelope Bridgerton has put down her quill! But Lady Whistledown? Shows no signs of slowing down. Part two of Bridgerton season 4 revealed Penelope’s retirement as the town gossip (heavy is the head, ...

Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases with two lead clinical programs approaching pivotal milestones. DYNE-101 shows strong safety and functional ...

An independent-minded female cabbie scrimps, scrapes and saves for a better life in Olive Nwosu's unpolished but promising debut. In some ways, Nwosu’s script subverts expectations. In others, it ...

Olive Nwosu’s debut feature is powered by striking images of the Nigerian city and its women. We are first introduced to Lagos through the eyes of Lady (Jessica Gabriel’s Ujah) and everything is ...

Dyne Therapeutics, Inc. faces a pivotal 2026 with key milestones for DYNE-101 and DYNE-251, supported by a well-timed $350M equity raise. The recent offering extends DYN's cash runway by roughly one ...

The biotech announced a secondary stock issue. It aims to sell $300 million worth of common shares. Just after market close on Monday, Dyne announced that it has launched an underwritten public ...